Bridge to Life Raises $110 Million for Organ Perfusion

Company: Bridge to Life · Event Type: Deal and Financing · Product/Asset: VitaSmart · Subject: Organ Perfusion · Event Date: August 12, 2026 Summary Bridge to Life completed $110 million of Series C equity and debt financing to expand the U.S. launch of its VitaSmart…

🔒

Continue reading this signal

Create a free InSilens account to unlock full articles, analysis, and deal context.

Create Free Account
Share this article :

Leave a Reply

Your email address will not be published. Required fields are marked *